Page 6 - Guidelines Panel News Today

The FDA made a reasonable decision — but one that still shows much of what’s wrong with our current system for emergency approvals.

U.S. regulators have rejected a request to grant emergency authorization to a cheap drug for the treatment of ...

For the first time, a federal health panel recommended against the use of ivermectin for the treatment of ...

The WHO's guidance comes as some patients and clinicians report recurring symptoms after patients finish a course of Paxlovid.

The members of COVID-19 Treatment Guidelines Panel of the NIH apparently doesn’t seem to place any value on human life. In this article, I will show several examples of this. At no time is there [...]

The best uncensored news, information, and analysis.

Study out of Ontario, Canada, finds an immediate diagnosis decrease of 34% in March 2020, followed by a slow and incomplete recovery

Studies called active. there are six of those. that stands for accelerating covid-19 therapeutic interventions and vaccines. the whole gamut of direct anti-virals and monoclonal antibodies. as i mentioned anti-virals like paxlovid and others, the trials were done by the nih. in direct answer to how we know what to use, the nih has put together a guidelines panel made up of 48 highly-qualified clinicians and individuals with experience in covid-19 to give a prioritization of what you do if you ar...

Avoid ivemectin, even if accessible through telemedicine. Read more on this condemned COVID treatment here and other unproven COVID drugs.

In June, the US government agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and in November agreed to buy an additional 1.4 billion courses for $1 billion.